Advanced search
Publication Cover
Expert Review of Anticancer Therapy Volume 19, 2019 - Issue 2
Submit an article Journal homepage
797
Views
10
CrossRef citations to date
0
Altmetric
Review

Prospects of targeted and immune therapies in SCLC

Lizza E. L. HendriksDepartment of Pulmonary Diseases, GROW – School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, the Netherlands;Department of Medical Oncology, Gustave Roussy, Institut d’Oncologie Thoracique (IOT), Gustave Roussy, Université Paris-Saclay, Villejuif, FranceCorrespondence[email protected]
View further author information
,
Jessica MenisMedical Oncology, University of Padua and Veneto Institute of Oncology IOV – IRCCS, Padua, ItalyView further author information
&
Martin ReckAirway Research Center North (ARCN), German Center for Lung Research, LungenClinic, Grosshansdorf, GermanyView further author information
Pages 151-167 | Received 30 Jul 2018, Accepted 10 Dec 2018, Published online: 28 Dec 2018

Citations (10)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Mingshuang Wu, Yi He & Chenxi Pan. (2023) Analysis of Baseline Serum Lipid Profile for Predicting Clinical Outcomes of Patients with Extensive-Stage Small Cell Lung Cancer. Cancer Management and Research 15, pages 773-783.
Read now
Lin Yu, Qinhuai Lai, Lantu Gou, Jiafu Feng & Jinliang Yang. (2021) Opportunities and obstacles of targeted therapy and immunotherapy in small cell lung cancer. Journal of Drug Targeting 29:1, pages 1-11.
Read now

Articles from other publishers (8)

Ziqian Song, Hengmin Ma, Hao Sun, Qiuxia Li, Yan Liu, Jing Xie, Yukun Feng, Yuwang Shang, Kena Ma, Nan Zhang & Jialin Wang. (2023) Construction and validation of a nomogram to predict the overall survival of small cell lung cancer: a multicenter retrospective study in Shandong province, China. BMC Cancer 23:1.
Crossref
Valeria Skopelidou, Jan Strakoš, Jozef Škarda, Milan Raška & Leona Kafková-Rašková. (2023) Potential predictors of immunotherapy in small cell lung cancer. Pathology and Oncology Research 29.
Crossref
Jun Ni, Xiaoyan Si, Hanping Wang, Xiaotong Zhang & Li Zhang. (2023) Prognostic biomarkers and immune cell infiltration characteristics in small cell lung cancer. Cancer Pathogenesis and Therapy 1:1, pages 18-24.
Crossref
Xueting Wang, Xianhu Zeng, Dan Li, Chunrong Zhu, Xusheng Guo, Lingxin Feng & Zhuang Yu. (2022) PARP inhibitors in small cell lung cancer: The underlying mechanisms and clinical implications. Biomedicine & Pharmacotherapy 153, pages 113458.
Crossref
Andrea Plaja, Teresa Moran, Enric Carcereny, Maria Saigi, Ainhoa Hernández, Marc Cucurull & Marta Domènech. (2021) Small-Cell Lung Cancer Long-Term Survivor Patients: How to Find a Needle in a Haystack?. International Journal of Molecular Sciences 22:24, pages 13508.
Crossref
Ming Chen, Runzhe Chen, Ying Jin, Jun Li, Xin Hu, Jiexin Zhang, Junya Fujimoto, Shawna M. Hubert, Carl M. Gay, Bo Zhu, Yanhua Tian, Nicholas McGranahan, Won-Chul Lee, Julie George, Xiao Hu, Yamei Chen, Meijuan Wu, Carmen Behrens, Chi-Wan Chow, Hoa H. N. Pham, Junya Fukuoka, Jia Wu, Edwin Roger Parra, Latasha D. Little, Curtis Gumbs, Xingzhi Song, Chang-Jiun Wu, Lixia Diao, Qi Wang, Robert Cardnell, Jianhua Zhang, Jing Wang, Xiuning Le, Don L. Gibbons, John V. Heymach, J. Jack Lee, William N. WilliamJrJr, Chao Cheng, Bonnie Glisson, Ignacio Wistuba, P. Andrew Futreal, Roman K. Thomas, Alexandre Reuben, Lauren A. Byers & Jianjun Zhang. (2021) Cold and heterogeneous T cell repertoire is associated with copy number aberrations and loss of immune genes in small-cell lung cancer. Nature Communications 12:1.
Crossref
Aierpati Maimaiti, Xixian Wang, Yujun Hao, Lei Jiang, Xin Shi, Yinan Pei, Zhaohai Feng & Maimaitijiang Kasimu. (2021) Integrated Gene Expression and Methylation Analyses Identify DLL3 as a Biomarker for Prognosis of Malignant Glioma. Journal of Molecular Neuroscience 71:8, pages 1622-1635.
Crossref
Lizza E.L. Hendriks, Jessica Menis, Dirk K.M. De Ruysscher & Martin Reck. (2020) Combination of Immunotherapy and Radiotherapy—The Next Magic Step in the Management of Lung Cancer?. Journal of Thoracic Oncology 15:2, pages 166-169.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.